Nath Bio-Genes (India) Limited has informed the Exchange regarding Resignation of Ms Shipra Agrawal as Other of the company w.e.f. July 03, 2025.
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ms. Shipra Agrawal (DIN: 09456482) has resigned from her position as Additional Director (Independent) of Nath Bio-Genes (India) Limited, effective July 3, 2025. She cited pre-occupation and personal reasons for her decision. She was not holding directorships in any other listed company and had no committee memberships. The disclosure has been made to both BSE and NSE in line with SEBI Listing Regulations. The resignation letter confirms there are no other material reasons beyond what has been stated.
This is a routine independent director exit with no governance red flags or performance concerns cited. For shareholders, the immediate impact is minimal, though the company will need to fill the vacant independent director seat to maintain statutory board composition requirements.